Sutro Biopharma, Inc.
STRONASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $189.91M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $7.15$43.85
- Volume (live)
- -
- Avg. volume (3M)
- 336.63K
Sutro Biopharma (STRO) Stock Price & Financial Analysis
Sutro Biopharma Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $10.59 - $11.47 |
|---|---|
| 52-Week High | $43.85 |
| 52-Week Low | $7.15 |
| Open | $11.47 |
| Volume (last close) | 363.46K |
| Average Volume (3M) | 336.63K |
| Revenue (TTM) | 45.70M |
|---|---|
| Net Income (TTM) | -180.64M |
| Free Cash Flow (TTM) | -145.62M |
| EPS (TTM) | −$15.46 |
| Profit Margin | -395.25% |
| Operating Margin | -288.52% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 189.91M |
|---|---|
| Shares Outstanding | 16.57M |
| Price to Sales (P/S) | 4.16 |
| Price to Book (P/B) | -1.84 |
| EV/EBITDA | -1.09 |
| 50-Day MA | $18.48 |
|---|---|
| 200-Day MA | $23.11 |
| 1-Year Change | +13.47% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Sutro Biopharma at a Glance
As of the Oct 16, 2026 close, Sutro Biopharma (STRO) has a market capitalization of $189.91M. The stock trades at 4.2× sales. Over the trailing twelve months it lost $180.64M on revenue of $45.70M and burned $145.62M of free cash flow. Revenue fell 56.3% year over year.
As of its latest reported balance sheet, it holds $54.34M in cash and securities against $10.78M of debt, a net cash position of $43.55M.
Sutro Biopharma does not currently pay a dividend.
The share price is up 13.5% over the past year. At $10.94 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $7.15 to $43.85, below its 200-day moving average of $23.11.
Based on 9 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $51.17, 367.7% above the Oct 16, 2026 close.
Frequently Asked Questions About Sutro Biopharma
What is the current stock price for STRO?
As of the Oct 16, 2026 close, STRO stock trades at $10.94. The 52-week range is $7.15–$43.85, with a day range of $10.59–$11.47.
What is the P/E ratio for STRO?
The P/E ratio (Price-to-Earnings) for STRO is shown in the Key Statistics section. This valuation metric helps compare Sutro Biopharma, Inc. to industry peers.
Does STRO pay dividends?
Sutro Biopharma does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for STRO?
Based on ratings from 9 professional analysts over the last 90 days, the consensus for STRO is Buy. The average 12-month price target is $51.17, a 367.7% upside from the Oct 16, 2026 close of $10.94.
What is the market cap of STRO?
As of the Oct 16, 2026 close, Sutro Biopharma's market capitalization is $181.3M, classifying it as a micro-cap company. Sutro Biopharma operates in the Healthcare sector within the Biotechnology industry.